

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.63535854 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.63535854 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.42815703 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.42815703 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.83103926 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.71655436 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50789339 |
| 8 | kynurenine metabolic process (GO:0070189) | 5.38750968 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 5.31437974 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 5.20324218 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.20107045 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.16712648 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.16712648 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.16712648 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.12195630 |
| 16 | urea cycle (GO:0000050) | 5.10375258 |
| 17 | urea metabolic process (GO:0019627) | 5.10375258 |
| 18 | cysteine metabolic process (GO:0006534) | 5.10211139 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98600938 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.94145443 |
| 21 | protein carboxylation (GO:0018214) | 4.89961701 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89961701 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.78370651 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 4.65500185 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.62709382 |
| 26 | regulation of cholesterol homeostasis (GO:2000188) | 4.61698918 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.57019404 |
| 28 | negative regulation of sterol transport (GO:0032372) | 4.55119388 |
| 29 | negative regulation of cholesterol transport (GO:0032375) | 4.55119388 |
| 30 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.49433069 |
| 31 | lysine catabolic process (GO:0006554) | 4.49209583 |
| 32 | lysine metabolic process (GO:0006553) | 4.49209583 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.48667864 |
| 34 | complement activation, alternative pathway (GO:0006957) | 4.45563867 |
| 35 | cellular modified amino acid catabolic process (GO:0042219) | 4.40709744 |
| 36 | bile acid metabolic process (GO:0008206) | 4.36337441 |
| 37 | regulation of complement activation (GO:0030449) | 4.31930375 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.30614878 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25450293 |
| 40 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.23856004 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.21928109 |
| 42 | proline biosynthetic process (GO:0006561) | 4.20723048 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.19406501 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.15907408 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.11754877 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.11754877 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.11754877 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.11082519 |
| 49 | glutamate metabolic process (GO:0006536) | 4.10473976 |
| 50 | glycine metabolic process (GO:0006544) | 4.10470948 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.05582672 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.04406039 |
| 53 | phospholipid efflux (GO:0033700) | 4.02713988 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.02578032 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.98935741 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.98935741 |
| 57 | ethanol oxidation (GO:0006069) | 3.96291913 |
| 58 | regulation of cholesterol esterification (GO:0010872) | 3.92932580 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 3.90595994 |
| 60 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.89799176 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.87518263 |
| 62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.86303222 |
| 63 | glucocorticoid biosynthetic process (GO:0006704) | 3.83695992 |
| 64 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.83246606 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 3.82813294 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.79713841 |
| 67 | COPI coating of Golgi vesicle (GO:0048205) | 3.74768479 |
| 68 | Golgi transport vesicle coating (GO:0048200) | 3.74768479 |
| 69 | cholesterol efflux (GO:0033344) | 3.71250955 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.70913761 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 3.67019481 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.65353468 |
| 73 | phospholipid homeostasis (GO:0055091) | 3.62955090 |
| 74 | fibrinolysis (GO:0042730) | 3.61068040 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.60077009 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.58816041 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 3.58309902 |
| 78 | indolalkylamine metabolic process (GO:0006586) | 3.56178357 |
| 79 | low-density lipoprotein particle clearance (GO:0034383) | 3.55118865 |
| 80 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.54294248 |
| 81 | drug catabolic process (GO:0042737) | 3.52845154 |
| 82 | cellular glucuronidation (GO:0052695) | 3.52661697 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.52648959 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51662808 |
| 85 | negative regulation of cell size (GO:0045792) | 3.49780178 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 3.44431237 |
| 87 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.42851379 |
| 88 | response to follicle-stimulating hormone (GO:0032354) | 3.42737681 |
| 89 | adherens junction assembly (GO:0034333) | 3.42685576 |
| 90 | drug transmembrane transport (GO:0006855) | 3.41985123 |
| 91 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.40564514 |
| 92 | protein-lipid complex assembly (GO:0065005) | 3.40056054 |
| 93 | ketone body metabolic process (GO:1902224) | 3.36938031 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.36741221 |
| 95 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.35852526 |
| 96 | sterol homeostasis (GO:0055092) | 3.35031145 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.34789979 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.34449021 |
| 99 | protein retention in ER lumen (GO:0006621) | 3.34386888 |
| 100 | proline metabolic process (GO:0006560) | 3.32252722 |
| 101 | urate metabolic process (GO:0046415) | 3.31115354 |
| 102 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.29716463 |
| 103 | aspartate family amino acid catabolic process (GO:0009068) | 3.29327497 |
| 104 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.25505663 |
| 105 | valine metabolic process (GO:0006573) | 3.22257249 |
| 106 | drug metabolic process (GO:0017144) | 3.20827200 |
| 107 | organic acid catabolic process (GO:0016054) | 3.20106943 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.20106943 |
| 109 | regulation of plasminogen activation (GO:0010755) | 3.19513393 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.18926109 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.18455344 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.17750610 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.17750610 |
| 114 | cell-substrate adherens junction assembly (GO:0007045) | 3.17716297 |
| 115 | focal adhesion assembly (GO:0048041) | 3.17716297 |
| 116 | arginine metabolic process (GO:0006525) | 3.16967968 |
| 117 | apoptotic process involved in morphogenesis (GO:0060561) | 3.16681828 |
| 118 | amine catabolic process (GO:0009310) | 3.16442320 |
| 119 | cellular biogenic amine catabolic process (GO:0042402) | 3.16442320 |
| 120 | progesterone metabolic process (GO:0042448) | 3.16031485 |
| 121 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.14873605 |
| 122 | linoleic acid metabolic process (GO:0043651) | 3.14803332 |
| 123 | blood coagulation, intrinsic pathway (GO:0007597) | 3.13845470 |
| 124 | glucocorticoid metabolic process (GO:0008211) | 3.13841004 |
| 125 | basement membrane organization (GO:0071711) | 3.08734817 |
| 126 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.06150570 |
| 127 | mannose metabolic process (GO:0006013) | 3.02264331 |
| 128 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.97322675 |
| 129 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.90996968 |
| 130 | * regulation of cholesterol biosynthetic process (GO:0045540) | 2.89166877 |
| 131 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.88942507 |
| 132 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.88375632 |
| 133 | diaphragm development (GO:0060539) | 2.87329207 |
| 134 | pentose-phosphate shunt (GO:0006098) | 2.87110496 |
| 135 | protein localization to endosome (GO:0036010) | 2.83308666 |
| 136 | cell-cell junction maintenance (GO:0045217) | 2.81135541 |
| 137 | C21-steroid hormone metabolic process (GO:0008207) | 2.81015591 |
| 138 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.75214309 |
| 139 | cellular protein complex localization (GO:0034629) | 2.74483806 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.72195845 |
| 141 | androgen biosynthetic process (GO:0006702) | 2.70915465 |
| 142 | glucose catabolic process (GO:0006007) | 2.70766502 |
| 143 | cell-substrate junction assembly (GO:0007044) | 2.69935086 |
| 144 | response to laminar fluid shear stress (GO:0034616) | 2.69882022 |
| 145 | negative regulation of fatty acid transport (GO:2000192) | 2.68229990 |
| 146 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.68183610 |
| 147 | mRNA stabilization (GO:0048255) | 2.67783853 |
| 148 | RNA stabilization (GO:0043489) | 2.67783853 |
| 149 | skeletal muscle organ development (GO:0060538) | 2.67072326 |
| 150 | activation of Rac GTPase activity (GO:0032863) | 2.62478660 |
| 151 | * regulation of cholesterol metabolic process (GO:0090181) | 2.61807678 |
| 152 | regulation of extracellular matrix disassembly (GO:0010715) | 2.60419452 |
| 153 | cellular response to gonadotropin stimulus (GO:0071371) | 2.60189209 |
| 154 | maternal placenta development (GO:0001893) | 2.59701567 |
| 155 | activation of MAPKKK activity (GO:0000185) | 2.59212266 |
| 156 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.56297484 |
| 157 | NADPH regeneration (GO:0006740) | 2.54620557 |
| 158 | semaphorin-plexin signaling pathway (GO:0071526) | 2.54597535 |
| 159 | protein-DNA complex disassembly (GO:0032986) | 2.52533992 |
| 160 | nucleosome disassembly (GO:0006337) | 2.52533992 |
| 161 | tricarboxylic acid metabolic process (GO:0072350) | 2.52164417 |
| 162 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.49491074 |
| 163 | epithelial cell-cell adhesion (GO:0090136) | 2.47395632 |
| 164 | diacylglycerol metabolic process (GO:0046339) | 2.47251511 |
| 165 | convergent extension (GO:0060026) | 2.46297942 |
| 166 | positive regulation of hormone metabolic process (GO:0032352) | 2.45813225 |
| 167 | regulation of ARF GTPase activity (GO:0032312) | 2.45745771 |
| 168 | positive regulation of nuclease activity (GO:0032075) | 2.43718261 |
| 169 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.41914937 |
| 170 | retrograde transport, endosome to Golgi (GO:0042147) | 2.41402770 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.38508773 |
| 172 | modulation by virus of host morphology or physiology (GO:0019048) | 2.38137161 |
| 173 | histone H4 deacetylation (GO:0070933) | 2.37979459 |
| 174 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.36209885 |
| 175 | amyloid precursor protein catabolic process (GO:0042987) | 2.36025024 |
| 176 | regulation of ARF protein signal transduction (GO:0032012) | 2.35881736 |
| 177 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34624542 |
| 178 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.33678692 |
| 179 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32495990 |
| 180 | atrioventricular valve morphogenesis (GO:0003181) | 2.31682009 |
| 181 | glucose 6-phosphate metabolic process (GO:0051156) | 2.30609887 |
| 182 | regulation of cholesterol storage (GO:0010885) | 2.30216590 |
| 183 | negative regulation of myotube differentiation (GO:0010832) | 2.30062887 |
| 184 | regulation of chromatin binding (GO:0035561) | 2.29923314 |
| 185 | negative regulation of granulocyte differentiation (GO:0030853) | 2.27085244 |
| 186 | modulation by virus of host process (GO:0019054) | 2.26211877 |
| 187 | protein complex localization (GO:0031503) | 2.25503019 |
| 188 | pinocytosis (GO:0006907) | 2.23761062 |
| 189 | protein targeting to plasma membrane (GO:0072661) | 2.23488849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.21745111 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.63294671 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.79971925 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16353185 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.01591110 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.89826146 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.80575189 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45134901 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.96558744 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30176419 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.27114780 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96347848 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95347937 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91632131 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87906691 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 1.85415352 |
| 17 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81262545 |
| 18 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.81094751 |
| 19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.78752553 |
| 20 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67953455 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62855671 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60835499 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57494663 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54710975 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52227312 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.50828028 |
| 27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.48764551 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47830354 |
| 29 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44419257 |
| 30 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43604750 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43240475 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42852963 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.41327097 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39100090 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38795512 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38586283 |
| 37 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36734581 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36199637 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35554459 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34992616 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30625503 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.29090540 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28765685 |
| 44 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.27338774 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26965177 |
| 46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26349568 |
| 47 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26037135 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26016667 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23117547 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22468487 |
| 51 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22403305 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21572449 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20739330 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18746265 |
| 55 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18529215 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18501847 |
| 57 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17779875 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16016854 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.14773290 |
| 60 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14457992 |
| 61 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14159708 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13801389 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13612134 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12771452 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12557347 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12295782 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12177809 |
| 68 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11809345 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11043352 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10400064 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10040596 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09638766 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09550057 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09282712 |
| 75 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07826702 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07579335 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07457149 |
| 78 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06993917 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06791055 |
| 80 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06506542 |
| 81 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03981535 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.03867608 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01947345 |
| 84 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01725182 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01724656 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01378450 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01081516 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01027424 |
| 89 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00732598 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00122803 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99530563 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99374391 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98851576 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96775671 |
| 95 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94963999 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.94698265 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93749115 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93078482 |
| 99 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91986211 |
| 100 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91555533 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89014544 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88676732 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88502900 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88338922 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87701590 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86041773 |
| 107 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.85923413 |
| 108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84778781 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83924337 |
| 110 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83745882 |
| 111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82012395 |
| 112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81965267 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81393763 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79854384 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79556932 |
| 116 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.79240928 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79195503 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79124885 |
| 119 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78850177 |
| 120 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.78850177 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77873832 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77399387 |
| 123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.77093525 |
| 124 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.77040305 |
| 125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.76974299 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76785820 |
| 127 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76579104 |
| 128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76246016 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76171651 |
| 130 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.75257417 |
| 131 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.74966037 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74518066 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74511825 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74276962 |
| 135 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74066230 |
| 136 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72936354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.63981607 |
| 2 | MP0005360_urolithiasis | 6.95741741 |
| 3 | MP0005365_abnormal_bile_salt | 5.65889849 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.58417214 |
| 5 | MP0000566_synostosis | 4.30320347 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.26840400 |
| 7 | MP0003252_abnormal_bile_duct | 3.80976807 |
| 8 | MP0009840_abnormal_foam_cell | 3.64114699 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.42296663 |
| 10 | MP0005076_abnormal_cell_differentiation | 3.11794764 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 3.09583979 |
| 12 | MP0008260_abnormal_autophagy | 2.88356554 |
| 13 | MP0005083_abnormal_biliary_tract | 2.76631228 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.75385367 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.61082565 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.53026716 |
| 17 | MP0003195_calcinosis | 2.48759617 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.43136295 |
| 19 | MP0005332_abnormal_amino_acid | 2.43076004 |
| 20 | MP0004233_abnormal_muscle_weight | 2.31789751 |
| 21 | MP0000537_abnormal_urethra_morphology | 2.24636859 |
| 22 | MP0005409_darkened_coat_color | 2.21299982 |
| 23 | * MP0000609_abnormal_liver_physiology | 2.18484617 |
| 24 | MP0003566_abnormal_cell_adhesion | 2.17579799 |
| 25 | MP0009278_abnormal_bone_marrow | 2.13337930 |
| 26 | * MP0002118_abnormal_lipid_homeostasis | 2.02755158 |
| 27 | MP0002249_abnormal_larynx_morphology | 1.93641744 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.90008503 |
| 29 | MP0000678_abnormal_parathyroid_gland | 1.86674221 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.82971025 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.79133953 |
| 32 | MP0003868_abnormal_feces_composition | 1.76017981 |
| 33 | MP0005451_abnormal_body_composition | 1.72741826 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.64962244 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.63995257 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.62832375 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.54514107 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.52363468 |
| 39 | MP0004272_abnormal_basement_membrane | 1.46704122 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43445642 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.41310364 |
| 42 | MP0002254_reproductive_system_inflammat | 1.38117839 |
| 43 | MP0000467_abnormal_esophagus_morphology | 1.34270854 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.34130003 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.32549188 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.30956431 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.27890286 |
| 48 | MP0003011_delayed_dark_adaptation | 1.27679778 |
| 49 | MP0000604_amyloidosis | 1.23439950 |
| 50 | MP0000598_abnormal_liver_morphology | 1.22982344 |
| 51 | MP0003091_abnormal_cell_migration | 1.21933372 |
| 52 | MP0003115_abnormal_respiratory_system | 1.20936406 |
| 53 | MP0003329_amyloid_beta_deposits | 1.18784942 |
| 54 | MP0005647_abnormal_sex_gland | 1.17630157 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 1.09749298 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.07572595 |
| 57 | MP0006138_congestive_heart_failure | 1.06710663 |
| 58 | MP0000733_abnormal_muscle_development | 1.06208504 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.04490595 |
| 60 | MP0000751_myopathy | 1.02232585 |
| 61 | MP0003436_decreased_susceptibility_to | 1.01144274 |
| 62 | MP0003942_abnormal_urinary_system | 0.97613072 |
| 63 | MP0000858_altered_metastatic_potential | 0.97272597 |
| 64 | MP0004381_abnormal_hair_follicle | 0.96829608 |
| 65 | MP0001730_embryonic_growth_arrest | 0.95414785 |
| 66 | MP0004130_abnormal_muscle_cell | 0.95032347 |
| 67 | MP0001764_abnormal_homeostasis | 0.93088855 |
| 68 | MP0001348_abnormal_lacrimal_gland | 0.91636491 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.89648888 |
| 70 | MP0002796_impaired_skin_barrier | 0.88029494 |
| 71 | MP0005257_abnormal_intraocular_pressure | 0.86366727 |
| 72 | MP0000639_abnormal_adrenal_gland | 0.86127491 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.85912098 |
| 74 | MP0003279_aneurysm | 0.85863791 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.85564029 |
| 76 | MP0001545_abnormal_hematopoietic_system | 0.85564029 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.85038263 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 0.82900429 |
| 79 | MP0003984_embryonic_growth_retardation | 0.82366950 |
| 80 | MP0005621_abnormal_cell_physiology | 0.81029908 |
| 81 | MP0003123_paternal_imprinting | 0.80880380 |
| 82 | MP0000477_abnormal_intestine_morphology | 0.80031408 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.79892100 |
| 84 | * MP0009642_abnormal_blood_homeostasis | 0.77863165 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.76776319 |
| 86 | MP0009763_increased_sensitivity_to | 0.75812687 |
| 87 | MP0000490_abnormal_crypts_of | 0.75560496 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.74754623 |
| 89 | MP0002060_abnormal_skin_morphology | 0.74654793 |
| 90 | MP0002088_abnormal_embryonic_growth/wei | 0.74042888 |
| 91 | MP0000579_abnormal_nail_morphology | 0.73868821 |
| 92 | MP0002086_abnormal_extraembryonic_tissu | 0.73410585 |
| 93 | MP0005670_abnormal_white_adipose | 0.73379130 |
| 94 | MP0002132_abnormal_respiratory_system | 0.72946383 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.72826318 |
| 96 | MP0005380_embryogenesis_phenotype | 0.72577064 |
| 97 | MP0001672_abnormal_embryogenesis/_devel | 0.72577064 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.72293311 |
| 99 | MP0003634_abnormal_glial_cell | 0.71970450 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.71802486 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.71621030 |
| 102 | MP0003283_abnormal_digestive_organ | 0.70707284 |
| 103 | MP0001756_abnormal_urination | 0.70120067 |
| 104 | MP0005334_abnormal_fat_pad | 0.69951385 |
| 105 | MP0003122_maternal_imprinting | 0.69919748 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.69402424 |
| 107 | MP0002822_catalepsy | 0.68931761 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.68476073 |
| 109 | MP0002080_prenatal_lethality | 0.68471584 |
| 110 | MP0000681_abnormal_thyroid_gland | 0.68406170 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.68266273 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.67928391 |
| 113 | MP0002932_abnormal_joint_morphology | 0.67568284 |
| 114 | MP0003075_altered_response_to | 0.66924180 |
| 115 | MP0009672_abnormal_birth_weight | 0.65897772 |
| 116 | MP0004858_abnormal_nervous_system | 0.64655996 |
| 117 | MP0002971_abnormal_brown_adipose | 0.64550993 |
| 118 | MP0002928_abnormal_bile_duct | 0.63900641 |
| 119 | MP0002092_abnormal_eye_morphology | 0.63516753 |
| 120 | MP0009931_abnormal_skin_appearance | 0.63176400 |
| 121 | MP0001849_ear_inflammation | 0.63043462 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.62989869 |
| 123 | MP0004808_abnormal_hematopoietic_stem | 0.62788236 |
| 124 | MP0001958_emphysema | 0.62551663 |
| 125 | MP0001873_stomach_inflammation | 0.62162594 |
| 126 | MP0001661_extended_life_span | 0.59939942 |
| 127 | MP0005408_hypopigmentation | 0.59491688 |
| 128 | MP0004947_skin_inflammation | 0.58128642 |
| 129 | MP0005023_abnormal_wound_healing | 0.56672434 |
| 130 | MP0001915_intracranial_hemorrhage | 0.56516821 |
| 131 | MP0008874_decreased_physiological_sensi | 0.55820282 |
| 132 | MP0008469_abnormal_protein_level | 0.55004819 |
| 133 | MP0002970_abnormal_white_adipose | 0.53324518 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.52924827 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.52506529 |
| 136 | MP0002168_other_aberrant_phenotype | 0.52304011 |
| 137 | MP0003953_abnormal_hormone_level | 0.52214895 |
| 138 | MP0009053_abnormal_anal_canal | 0.51512752 |
| 139 | MP0005448_abnormal_energy_balance | 0.51100878 |
| 140 | MP0000377_abnormal_hair_follicle | 0.50917127 |
| 141 | MP0001944_abnormal_pancreas_morphology | 0.49972956 |
| 142 | MP0003303_peritoneal_inflammation | 0.49762914 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.49469738 |
| 144 | MP0001243_abnormal_dermal_layer | 0.49098107 |
| 145 | MP0005248_abnormal_Harderian_gland | 0.48307793 |
| 146 | MP0001881_abnormal_mammary_gland | 0.47062183 |
| 147 | MP0001765_abnormal_ion_homeostasis | 0.46986117 |
| 148 | MP0005535_abnormal_body_temperature | 0.46867354 |
| 149 | MP0005166_decreased_susceptibility_to | 0.46725564 |
| 150 | MP0009764_decreased_sensitivity_to | 0.46518088 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.46325645 |
| 152 | MP0003690_abnormal_glial_cell | 0.45768414 |
| 153 | MP0005187_abnormal_penis_morphology | 0.44067670 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.43927404 |
| 155 | MP0003699_abnormal_female_reproductive | 0.43226662 |
| 156 | MP0005395_other_phenotype | 0.42806208 |
| 157 | MP0005501_abnormal_skin_physiology | 0.42735184 |
| 158 | MP0000427_abnormal_hair_cycle | 0.42097446 |
| 159 | MP0005376_homeostasis/metabolism_phenot | 0.41032744 |
| 160 | MP0003186_abnormal_redox_activity | 0.40727165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.32060104 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.28971360 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.19527018 |
| 4 | Xanthomatosis (HP:0000991) | 5.92834160 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.42908974 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.92597549 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.73963159 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.67166905 |
| 9 | Complement deficiency (HP:0004431) | 4.40318093 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.01490558 |
| 11 | Ketosis (HP:0001946) | 4.00661318 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.99120170 |
| 13 | Epidermoid cyst (HP:0200040) | 3.95043174 |
| 14 | Hyperammonemia (HP:0001987) | 3.90264543 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.83090398 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.73082227 |
| 17 | Hyperglycinemia (HP:0002154) | 3.70811853 |
| 18 | Joint hemorrhage (HP:0005261) | 3.69612943 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66860377 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55484747 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.49004597 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.38303249 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38303249 |
| 24 | Hyperglycinuria (HP:0003108) | 3.33798703 |
| 25 | Abnormality of the fingertips (HP:0001211) | 3.29435275 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.23485494 |
| 27 | Fat malabsorption (HP:0002630) | 3.22633588 |
| 28 | Abnormality of complement system (HP:0005339) | 3.13716521 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.10282872 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.05514376 |
| 31 | Myocardial infarction (HP:0001658) | 3.00200270 |
| 32 | Hepatocellular carcinoma (HP:0001402) | 3.00054965 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.98880245 |
| 34 | Gout (HP:0001997) | 2.96955975 |
| 35 | Hypercholesterolemia (HP:0003124) | 2.90259040 |
| 36 | Flat acetabular roof (HP:0003180) | 2.89725737 |
| 37 | Skin nodule (HP:0200036) | 2.88812465 |
| 38 | Ketoacidosis (HP:0001993) | 2.86919272 |
| 39 | Abnormality of the Achilles tendon (HP:0005109) | 2.85537343 |
| 40 | Hyperacusis (HP:0010780) | 2.82139342 |
| 41 | Disproportionate tall stature (HP:0001519) | 2.80829017 |
| 42 | Ulnar bowing (HP:0003031) | 2.78583517 |
| 43 | Broad face (HP:0000283) | 2.75928478 |
| 44 | Spastic diplegia (HP:0001264) | 2.74036674 |
| 45 | Obstructive sleep apnea (HP:0002870) | 2.69182614 |
| 46 | Hyperbilirubinemia (HP:0002904) | 2.67801382 |
| 47 | Shallow orbits (HP:0000586) | 2.57787592 |
| 48 | Neonatal onset (HP:0003623) | 2.57148742 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.53464565 |
| 50 | Mitral stenosis (HP:0001718) | 2.50788758 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.48475082 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47137244 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.46822978 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.44997095 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.44461567 |
| 56 | Sparse lateral eyebrow (HP:0005338) | 2.43568970 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43255120 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.41801560 |
| 59 | Long palpebral fissure (HP:0000637) | 2.41173975 |
| 60 | Abnormality of the lower motor neuron (HP:0002366) | 2.41016676 |
| 61 | Bronchomalacia (HP:0002780) | 2.40722599 |
| 62 | Esophageal varix (HP:0002040) | 2.32926483 |
| 63 | Lymphangioma (HP:0100764) | 2.31577097 |
| 64 | Late onset (HP:0003584) | 2.29721647 |
| 65 | Spontaneous abortion (HP:0005268) | 2.28755762 |
| 66 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.27112356 |
| 67 | Malnutrition (HP:0004395) | 2.26874330 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25307452 |
| 69 | Cervical subluxation (HP:0003308) | 2.24417389 |
| 70 | Premature skin wrinkling (HP:0100678) | 2.24246571 |
| 71 | Achilles tendon contracture (HP:0001771) | 2.23375370 |
| 72 | Anal stenosis (HP:0002025) | 2.23227275 |
| 73 | Abnormality of serum amino acid levels (HP:0003112) | 2.21449705 |
| 74 | Abnormality of the thoracic spine (HP:0100711) | 2.21058082 |
| 75 | Vertebral compression fractures (HP:0002953) | 2.20971957 |
| 76 | Steatorrhea (HP:0002570) | 2.19522726 |
| 77 | Back pain (HP:0003418) | 2.18004538 |
| 78 | Irritability (HP:0000737) | 2.16505595 |
| 79 | Advanced eruption of teeth (HP:0006288) | 2.14895256 |
| 80 | Amyloidosis (HP:0011034) | 2.13162768 |
| 81 | Biconcave vertebral bodies (HP:0004586) | 2.12915373 |
| 82 | Increased connective tissue (HP:0009025) | 2.11972904 |
| 83 | Premature rupture of membranes (HP:0001788) | 2.11839554 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.11751165 |
| 85 | Turricephaly (HP:0000262) | 2.11179407 |
| 86 | Vascular calcification (HP:0004934) | 2.11098443 |
| 87 | Acanthocytosis (HP:0001927) | 2.10762275 |
| 88 | Asymmetry of the thorax (HP:0001555) | 2.08791169 |
| 89 | Dysmetric saccades (HP:0000641) | 2.08788692 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07611436 |
| 91 | Thoracic kyphosis (HP:0002942) | 2.06689691 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06489972 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.06489972 |
| 94 | Eczematoid dermatitis (HP:0000976) | 2.06293342 |
| 95 | Abnormal cartilage morphology (HP:0002763) | 2.06142551 |
| 96 | Blue sclerae (HP:0000592) | 2.05630184 |
| 97 | Metabolic acidosis (HP:0001942) | 2.04938446 |
| 98 | Metaphyseal cupping (HP:0003021) | 2.03590100 |
| 99 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03251694 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 2.02051799 |
| 101 | Self-mutilation (HP:0000742) | 2.01529741 |
| 102 | Pseudobulbar signs (HP:0002200) | 2.01386123 |
| 103 | Menorrhagia (HP:0000132) | 2.00304644 |
| 104 | Abnormal ossification of hand bones (HP:0005921) | 2.00287864 |
| 105 | Abnormality of carpal bone ossification (HP:0006257) | 2.00133216 |
| 106 | Cardiovascular calcification (HP:0011915) | 1.99044267 |
| 107 | Cholelithiasis (HP:0001081) | 1.98870467 |
| 108 | Gingival bleeding (HP:0000225) | 1.92566026 |
| 109 | Precocious puberty (HP:0000826) | 1.91196688 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89284867 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89284867 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89284867 |
| 113 | Protuberant abdomen (HP:0001538) | 1.87851211 |
| 114 | Thin ribs (HP:0000883) | 1.87430259 |
| 115 | Growth hormone excess (HP:0000845) | 1.86144731 |
| 116 | Neonatal short-limb short stature (HP:0008921) | 1.86070861 |
| 117 | Sensorimotor neuropathy (HP:0007141) | 1.84798445 |
| 118 | Reticulocytosis (HP:0001923) | 1.84466903 |
| 119 | Neonatal death (HP:0003811) | 1.83439128 |
| 120 | Germ cell neoplasia (HP:0100728) | 1.82883305 |
| 121 | Death in childhood (HP:0003819) | 1.82774290 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 1.82266456 |
| 123 | Cholecystitis (HP:0001082) | 1.82266456 |
| 124 | Global brain atrophy (HP:0002283) | 1.82265531 |
| 125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81808906 |
| 126 | Thin bony cortex (HP:0002753) | 1.81453489 |
| 127 | Lip pit (HP:0100267) | 1.81117325 |
| 128 | Increased variability in muscle fiber diameter (HP:0003557) | 1.79925142 |
| 129 | Peritonitis (HP:0002586) | 1.79578515 |
| 130 | Cellulitis (HP:0100658) | 1.79308800 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.78436090 |
| 132 | Dysostosis multiplex (HP:0000943) | 1.78132406 |
| 133 | Natal tooth (HP:0000695) | 1.77772453 |
| 134 | Stridor (HP:0010307) | 1.77282683 |
| 135 | Aplasia involving bones of the extremities (HP:0009825) | 1.77230393 |
| 136 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77230393 |
| 137 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77230393 |
| 138 | Cortical dysplasia (HP:0002539) | 1.76784744 |
| 139 | Annular pancreas (HP:0001734) | 1.75711555 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.75310259 |
| 141 | Visceral angiomatosis (HP:0100761) | 1.75277160 |
| 142 | Neurofibrillary tangles (HP:0002185) | 1.74508597 |
| 143 | Distal lower limb amyotrophy (HP:0008944) | 1.74467020 |
| 144 | Stroke (HP:0001297) | 1.74348305 |
| 145 | Hemangiomatosis (HP:0007461) | 1.74049031 |
| 146 | Status epilepticus (HP:0002133) | 1.74029307 |
| 147 | Bowel incontinence (HP:0002607) | 1.73716939 |
| 148 | Limb hypertonia (HP:0002509) | 1.72496887 |
| 149 | Abnormality of the aortic arch (HP:0012303) | 1.71581926 |
| 150 | Pointed chin (HP:0000307) | 1.71539921 |
| 151 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.70653829 |
| 152 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.69766366 |
| 153 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.69766366 |
| 154 | Arnold-Chiari malformation (HP:0002308) | 1.68319629 |
| 155 | Aneurysm (HP:0002617) | 1.68174316 |
| 156 | Short 5th finger (HP:0009237) | 1.68038623 |
| 157 | Ureteral stenosis (HP:0000071) | 1.68027407 |
| 158 | Hyperglycemia (HP:0003074) | 1.67793629 |
| 159 | Enlarged kidneys (HP:0000105) | 1.67490247 |
| 160 | Increased mean platelet volume (HP:0011877) | 1.67172418 |
| 161 | Broad thumb (HP:0011304) | 1.65855376 |
| 162 | Distal upper limb amyotrophy (HP:0007149) | 1.65487202 |
| 163 | Upper limb amyotrophy (HP:0009129) | 1.65487202 |
| 164 | Nephrolithiasis (HP:0000787) | 1.64369500 |
| 165 | Seborrheic dermatitis (HP:0001051) | 1.63862491 |
| 166 | Elevated alkaline phosphatase (HP:0003155) | 1.63773128 |
| 167 | Broad distal phalanx of finger (HP:0009836) | 1.63693179 |
| 168 | Mitral valve prolapse (HP:0001634) | 1.62631155 |
| 169 | Mitral regurgitation (HP:0001653) | 1.62473029 |
| 170 | Broad palm (HP:0001169) | 1.62454086 |
| 171 | Poikilocytosis (HP:0004447) | 1.61870408 |
| 172 | Thrombophlebitis (HP:0004418) | 1.61566059 |
| 173 | Dislocated radial head (HP:0003083) | 1.61433060 |
| 174 | Ankyloglossia (HP:0010296) | 1.61347570 |
| 175 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.61166124 |
| 176 | Polycythemia (HP:0001901) | 1.61070414 |
| 177 | Abnormal vertebral ossification (HP:0100569) | 1.60695422 |
| 178 | Polygenic inheritance (HP:0010982) | 1.59524303 |
| 179 | Hypertriglyceridemia (HP:0002155) | 1.58339471 |
| 180 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.57738094 |
| 181 | Arachnodactyly (HP:0001166) | 1.56779745 |
| 182 | Gastrointestinal dysmotility (HP:0002579) | 1.56441769 |
| 183 | Hand muscle atrophy (HP:0009130) | 1.54811637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.01174706 |
| 2 | ERN1 | 4.29870467 |
| 3 | EEF2K | 3.44064497 |
| 4 | MAP3K10 | 3.43139134 |
| 5 | SIK1 | 3.37740369 |
| 6 | PKN2 | 3.33995158 |
| 7 | PRPF4B | 3.25957603 |
| 8 | SMG1 | 3.21118334 |
| 9 | FGFR4 | 2.67049782 |
| 10 | BCKDK | 2.65949449 |
| 11 | TAOK3 | 2.08596778 |
| 12 | LATS1 | 1.98594887 |
| 13 | RIPK1 | 1.91229805 |
| 14 | CDK12 | 1.85002588 |
| 15 | PTK6 | 1.78991703 |
| 16 | MAP3K7 | 1.61930462 |
| 17 | TAOK1 | 1.61721989 |
| 18 | MAP2K3 | 1.58057353 |
| 19 | TYRO3 | 1.49246415 |
| 20 | TESK2 | 1.46730419 |
| 21 | FGFR2 | 1.42461141 |
| 22 | KSR2 | 1.38678215 |
| 23 | GRK6 | 1.37096221 |
| 24 | LATS2 | 1.31974004 |
| 25 | IRAK3 | 1.31285742 |
| 26 | CAMK1D | 1.30968812 |
| 27 | ICK | 1.27757481 |
| 28 | ERBB4 | 1.23524841 |
| 29 | CAMK1G | 1.23366830 |
| 30 | PDGFRA | 1.17163254 |
| 31 | EPHA2 | 1.16452144 |
| 32 | EPHB1 | 1.13051812 |
| 33 | SCYL2 | 1.11362058 |
| 34 | MAPK11 | 1.09812398 |
| 35 | PRKD3 | 1.09549239 |
| 36 | MTOR | 1.07113034 |
| 37 | RET | 1.06822412 |
| 38 | MAP2K4 | 1.06734933 |
| 39 | MAP3K2 | 1.04219332 |
| 40 | TAOK2 | 1.04155492 |
| 41 | RPS6KC1 | 1.03194230 |
| 42 | RPS6KL1 | 1.03194230 |
| 43 | TNK2 | 1.03085026 |
| 44 | PAK6 | 1.01148978 |
| 45 | MAP4K1 | 0.97112977 |
| 46 | SIK2 | 0.96697162 |
| 47 | STK24 | 0.95069312 |
| 48 | MAP3K9 | 0.94589735 |
| 49 | DAPK2 | 0.93013279 |
| 50 | JAK2 | 0.88220107 |
| 51 | PRKCH | 0.87215353 |
| 52 | CDC42BPA | 0.86199078 |
| 53 | LRRK2 | 0.85821268 |
| 54 | LMTK2 | 0.85277479 |
| 55 | MAP3K13 | 0.84872172 |
| 56 | PAK4 | 0.83849071 |
| 57 | PTK2 | 0.83307962 |
| 58 | BMX | 0.80629382 |
| 59 | FRK | 0.79148623 |
| 60 | RPS6KA6 | 0.77897666 |
| 61 | MAP3K6 | 0.77187916 |
| 62 | CDK7 | 0.76465112 |
| 63 | FGFR3 | 0.76287320 |
| 64 | MAP3K3 | 0.75985351 |
| 65 | MAP3K1 | 0.75346486 |
| 66 | TYK2 | 0.73996217 |
| 67 | NTRK1 | 0.70269402 |
| 68 | RIPK4 | 0.70077163 |
| 69 | CAMKK1 | 0.68277338 |
| 70 | ALK | 0.67909525 |
| 71 | CDK6 | 0.67751596 |
| 72 | MOS | 0.66976665 |
| 73 | MST1R | 0.66121336 |
| 74 | JAK1 | 0.65434898 |
| 75 | PAK3 | 0.64609072 |
| 76 | HIPK2 | 0.64491136 |
| 77 | MARK2 | 0.64354633 |
| 78 | PAK2 | 0.62368462 |
| 79 | SGK3 | 0.61363249 |
| 80 | CDK4 | 0.60725782 |
| 81 | WNK1 | 0.60466640 |
| 82 | MAPK12 | 0.59867444 |
| 83 | DYRK1B | 0.57557976 |
| 84 | PDK1 | 0.56032137 |
| 85 | ARAF | 0.55677323 |
| 86 | GSK3A | 0.54952543 |
| 87 | PDPK1 | 0.53681606 |
| 88 | TESK1 | 0.53521443 |
| 89 | PRKD1 | 0.53116202 |
| 90 | ILK | 0.52824514 |
| 91 | ERBB2 | 0.51899819 |
| 92 | PRKAA2 | 0.51630780 |
| 93 | PRKAA1 | 0.51261473 |
| 94 | STK3 | 0.49751367 |
| 95 | MAP2K2 | 0.49061633 |
| 96 | INSRR | 0.48628352 |
| 97 | CDK9 | 0.47867454 |
| 98 | MAP3K8 | 0.47652453 |
| 99 | MAPK4 | 0.47532803 |
| 100 | ZAP70 | 0.47471496 |
| 101 | STK38 | 0.46846730 |
| 102 | FLT3 | 0.46246980 |
| 103 | HCK | 0.45705857 |
| 104 | EPHA4 | 0.45279636 |
| 105 | CCNB1 | 0.45203236 |
| 106 | KDR | 0.44279295 |
| 107 | IRAK4 | 0.43595318 |
| 108 | PRKG2 | 0.43216365 |
| 109 | IRAK2 | 0.43091557 |
| 110 | PRKCZ | 0.42529805 |
| 111 | RPS6KA2 | 0.42516970 |
| 112 | CSF1R | 0.42441647 |
| 113 | TTN | 0.42246436 |
| 114 | PRKD2 | 0.42110280 |
| 115 | EPHA3 | 0.41975102 |
| 116 | STK10 | 0.41507056 |
| 117 | STK11 | 0.40387554 |
| 118 | CAMK4 | 0.40261868 |
| 119 | AKT2 | 0.39198121 |
| 120 | NME2 | 0.37044924 |
| 121 | MAP2K1 | 0.36426459 |
| 122 | RPS6KB2 | 0.35078195 |
| 123 | RAF1 | 0.33997567 |
| 124 | MAPK10 | 0.33717676 |
| 125 | NEK6 | 0.33481717 |
| 126 | RPS6KA1 | 0.33325178 |
| 127 | BRD4 | 0.32825201 |
| 128 | CHUK | 0.32818093 |
| 129 | FES | 0.32632638 |
| 130 | FER | 0.32469080 |
| 131 | MAP3K4 | 0.32273082 |
| 132 | CAMK1 | 0.32237434 |
| 133 | TGFBR2 | 0.31786588 |
| 134 | PIM2 | 0.31736570 |
| 135 | JAK3 | 0.31533213 |
| 136 | FGFR1 | 0.31531748 |
| 137 | PDGFRB | 0.31477086 |
| 138 | PRKACG | 0.31021469 |
| 139 | MAPKAPK3 | 0.30451370 |
| 140 | MAPK7 | 0.30447517 |
| 141 | MAP3K11 | 0.29911244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.25037848 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17936288 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45268367 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43394936 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06039375 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67242334 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53344020 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51023311 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.49996192 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43835487 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.32777826 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27016758 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18642682 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03022367 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93900014 |
| 16 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.93391669 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89168470 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87945800 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84936122 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.84077622 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78059497 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71743015 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71084749 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65650193 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.64463429 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63334869 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60158194 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60129689 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55651804 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54790129 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54007999 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52841533 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50344803 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48842599 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40198405 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35356623 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33423274 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31370338 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.28815129 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.27427114 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24910735 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23871260 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22469642 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20012171 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18881986 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.17977228 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15239952 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14167295 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13973133 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13358615 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11850863 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11444217 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11013474 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10836090 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09983710 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09391754 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.09368033 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07260844 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02761955 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01204510 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00520161 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99112807 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96011931 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93781465 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93729810 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92516454 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89884917 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89513207 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88546106 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.86752869 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84576014 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84383011 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80295296 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80123157 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78931615 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.78746683 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78158214 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76532550 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76138721 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76047926 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74871668 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74466071 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74249902 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72600265 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71855205 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69578280 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.69377432 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68729560 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.68577228 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.68453668 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68343604 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.68088771 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.67651998 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67587197 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67334726 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62486765 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59227746 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59072964 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57351237 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55144083 |
| 101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54781968 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51519665 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.50525175 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.48082775 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47417623 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45038173 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.44797806 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44352114 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43209106 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36639541 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36088731 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35764528 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35550709 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29053498 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28440770 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28326304 |
| 117 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27841519 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26683230 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26523371 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25690160 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24379602 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24062786 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22925991 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21111188 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.18443542 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.18398878 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.17710009 |
| 128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17263106 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16480002 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15078072 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.14655958 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.13987237 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13665454 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13201104 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12013307 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10505784 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.09552903 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.08776737 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08439866 |
| 140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07034512 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.05502424 |
| 142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.04731241 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.04424741 |

